RadNet (FRA:PQIA) Moat Score: 5/10 (As of Jul. 08, 2026)


FRA:PQIA RadNet Inc FRA:PQIA
75 GF Score
Price €59.48
GF Value €58.92
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is RadNet Moat Score?

RadNet FRA:PQIA -1.13% 75 Moat Score is 5 as of Jul. 08, 2026. GuruFocus rates FRA:PQIA with a GF Score™ of 75/100 and a GF Value™ of €58.92 (Fairly Valued). The stock has 5 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, RadNet ranks better than 87.5% on this metric.

RadNet has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

RadNet has Narrow Moat: RadNet Inc has a solid narrow moat due to its extensive network of imaging centers and some pricing power. The company benefits from economies of scale and a strong distribution network, but the healthcare industry's competitive nature limits its ability to achieve a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes RadNet might have Narrow Moat - Solid narrow moat.

RadNet  (FRA:PQIA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

RadNet Moat Score Related Terms

FRA:PQIA vs VCYT, SHC, BLLN: Moat Score Comparison

For the Diagnostics & Research subindustry, RadNet's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RadNet Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's Moat Score distribution charts can be found below:

* The bar in red indicates where RadNet's Moat Score falls into.


FRA:PQIA
75GF Score
RadNet Inc FRA:PQIA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
RadNet (FRA:PQIA) has a Moat Score of 5 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, RadNet ranks #27 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 12.5%.
Is RadNet's Moat Score too high?
RadNet's current Moat Score is 5. Based on the distribution chart, RadNet ranks #27 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, RadNet has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RadNet's Moat Score compare to VCYT and SHC?
According to the Medical Diagnostics & Research industry distribution chart, RadNet ranks #27 out of 216 companies for Moat Score. This places RadNet in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. RadNet's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RadNet stock overvalued right now?
Based on GuruFocus' analysis, RadNet (FRA:PQIA) is currently considered Fairly Valued. The stock's GF Value™ is €58.92, compared to a current price of €59.48 — trading 1% above its estimated fair value. The current Moat Score is 5. RadNet's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For RadNet (FRA:PQIA), the current Moat Score is 5 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RadNet (FRA:PQIA) Overvalued in 2026?

Based on GuruFocus' analysis, RadNet stock appears to be overvalued. The current stock price of €59.48 is trading 1% above its estimated GF Value™ of €58.92. GuruFocus considers RadNet to be Fairly Valued.

Key valuation signals for FRA:PQIA:

  • Moat Score: 5
  • GF Value™: €58.92 vs. price of €59.48 (1% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the FRA:PQIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RadNet Business Description

Other Exchanges RDNT:USARDNT:Mexico
Address 1510 Cotner Avenue, Los Angeles, CA, USA, 90025
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
75GF Score

Get the complete analysis for FRA:PQIA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.48
Price
€58.92
GF Value